Shandong Weigao Group Medical Polymer Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Shandong Weigao Group Medical Polymer yıllık ortalama 4.2% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 14.7% annual. Gelirler growing yılda ortalama 6.4% oranında artmaktadır. Shandong Weigao Group Medical Polymer'in özkaynak karlılığı 8% ve net marjı 14.7%'dir.
Anahtar bilgiler
4.2%
Kazanç büyüme oranı
4.0%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 13.7% |
Gelir büyüme oranı | 6.4% |
Özkaynak getirisi | 8.0% |
Net Marj | 14.7% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital
Nov 04Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report
Sep 24Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target
Aug 30Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Apr 23Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results
Mar 28Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon
Jan 09Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 22Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?
Nov 10Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Oct 05Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing
Aug 01Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?
Jul 19Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Jun 22Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?
Jun 09The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Apr 27Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Feb 27Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes
Jan 18Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Dec 12Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate
Nov 29Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Nov 14Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year
Oct 03The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Sep 21Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt
Sep 05Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price
Aug 23Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors
Aug 08There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital
Jun 22Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year
Jun 08An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued
May 16Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
May 03Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher
Mar 17Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?
Jan 28Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?
Jan 13Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 17Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
Dec 05An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued
Oct 18Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?
Oct 06Gelir ve Gider Dağılımı
Shandong Weigao Group Medical Polymer nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 12,967 | 1,912 | 3,778 | 600 |
31 Mar 24 | 13,098 | 1,957 | 3,807 | 596 |
31 Dec 23 | 13,229 | 2,002 | 3,837 | 593 |
30 Sep 23 | 13,398 | 2,221 | 3,793 | 597 |
30 Jun 23 | 13,566 | 2,440 | 3,748 | 602 |
31 Mar 23 | 13,657 | 2,602 | 3,721 | 579 |
31 Dec 22 | 13,747 | 2,764 | 3,694 | 556 |
30 Sep 22 | 13,903 | 2,676 | 3,725 | 551 |
30 Jun 22 | 14,058 | 2,589 | 3,755 | 546 |
31 Mar 22 | 13,633 | 2,432 | 3,793 | 525 |
31 Dec 21 | 13,209 | 2,276 | 3,830 | 503 |
30 Sep 21 | 12,923 | 2,288 | 3,865 | 493 |
30 Jun 21 | 12,636 | 2,300 | 3,900 | 484 |
31 Mar 21 | 12,129 | 2,194 | 3,775 | 454 |
31 Dec 20 | 11,622 | 2,087 | 3,651 | 424 |
30 Sep 20 | 11,139 | 1,998 | 3,636 | 403 |
30 Jun 20 | 10,656 | 1,909 | 3,622 | 382 |
31 Mar 20 | 10,520 | 1,879 | 3,699 | 394 |
31 Dec 19 | 10,384 | 1,850 | 3,776 | 406 |
30 Sep 19 | 9,993 | 1,805 | 3,696 | 374 |
30 Jun 19 | 9,602 | 1,760 | 3,615 | 341 |
31 Mar 19 | 9,205 | 1,616 | 3,500 | 326 |
31 Dec 18 | 8,809 | 1,473 | 3,385 | 311 |
30 Jun 18 | 7,465 | 1,255 | 2,842 | 280 |
31 Mar 18 | 6,879 | 1,255 | 2,593 | 277 |
31 Dec 17 | 6,293 | 1,255 | 2,344 | 274 |
30 Jun 17 | 5,402 | 1,297 | 1,918 | 258 |
31 Mar 17 | 5,511 | 1,165 | 2,062 | 262 |
31 Dec 16 | 5,620 | 1,033 | 2,206 | 266 |
30 Sep 16 | 6,484 | 1,010 | 2,469 | 302 |
30 Jun 16 | 6,237 | 914 | 2,367 | 302 |
31 Mar 16 | 6,078 | 1,013 | 2,153 | 297 |
31 Dec 15 | 5,919 | 1,113 | 1,938 | 293 |
30 Sep 15 | 5,878 | 1,237 | 1,920 | 290 |
30 Jun 15 | 5,610 | 1,196 | 1,839 | 262 |
31 Mar 15 | 5,548 | 1,161 | 1,828 | 252 |
31 Dec 14 | 5,278 | 1,085 | 1,742 | 238 |
30 Sep 14 | 5,011 | 307 | 1,646 | 222 |
30 Jun 14 | 4,996 | 431 | 1,583 | 222 |
31 Mar 14 | 4,769 | 376 | 1,521 | 215 |
31 Dec 13 | 4,613 | 388 | 1,453 | 209 |
Kaliteli Kazançlar: 1066 yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: 1066 'nin mevcut net kar marjları (14.7%) geçen yılın (18%) değerinden daha düşüktür.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 1066 şirketinin kazancı son 5 yılda yılda 4.2% oranında arttı.
Büyüme Hızlandırma: 1066 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.
Kazançlar vs. Sektör: 1066 geçtiğimiz yıl negatif kazanç büyümesine ( -21.6% ) sahipti ve bu da onu Medical Equipment sektör ortalamasıyla ( -4.3% ) karşılaştırmayı zorlaştırıyordu.
Özkaynak Getirisi
Yüksek ROE: 1066 'nin Özsermaye Getirisi ( 8% ) düşük olarak değerlendiriliyor.